(Q28236043)

Crossref

DOI

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

30 November 2024

1 reference

Petri T Kovanen

0 references

Kristiina Rajamäki

object named as

Kristiina Rajamäki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21508263

30 November 2024

Marc H. Baumann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21508263

30 November 2024

Katariina Öörni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21508263

30 November 2024

author name string

Katri Niemi

0 references

Laura Teirilä

0 references

Jani Lappalainen

0 references

Henrik Wolff

0 references

Sampsa Matikainen

0 references

Kari K. Eklund

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21508263

30 November 2024

language of work or name

English

0 references

publication date

1 June 2011

0 references

20 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21508263

full work available at URL

30 November 2024

published in

Journal of Immunology

0 references

volume

186

0 references

issue

0 references

page(s)

6119-28

0 references

cites work

A cell culture system for the study of amyloid pathogenesis. Amyloid formation by peritoneal macrophages cultured with recombinant serum amyloid A

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S0002-9440(10)65107-3

Regulation of serum amyloid A protein expression during the acute-phase response

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Human serum amyloid A has cytokine-like properties

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Serum amyloid A (SAA) activates human mast cells which leads into degradation of SAA and generation of an amyloidogenic SAA fragment

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Primer: inflammasomes and interleukin 1beta in inflammatory disorders

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

IL-1, IL-18, and IL-33 families of cytokines

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Toll-like receptors and innate immunity

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Cryopyrin activates the inflammasome in response to toxins and ATP

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Pannexin-1-Mediated Recognition of Bacterial Molecules Activates the Cryopyrin Inflammasome Independent of Toll-like Receptor Signaling

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

(1,3)-beta-glucans activate both dectin-1 and NLRP3 inflammasome in human macrophages

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Gout-associated uric acid crystals activate the NALP3 inflammasome

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

The NALP3 inflammasome is involved in the innate immune response to amyloid-beta

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Cathepsin B generates the most common form of amyloid A (76 residues) as a degradation product from serum amyloid A

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation.

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Acute-phase HDL in phospholipid transfer protein (PLTP)-mediated HDL conversion

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

ATP release by infected bovine monocytes increases the intracellular survival of Mycobacterium avium subsp. paratuberculosis

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Serum amyloid A induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Is serum amyloid A an endogenous TLR4 agonist?

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2.

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Novel Inhibitors of Cytokine-induced IκBα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in Vivo

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Double-stranded RNA-induced inducible nitric-oxide synthase expression and interleukin-1 release by murine macrophages requires NF-kappaB activation

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

LPS induction of gene expression in human monocytes

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Inflammatory caspases and inflammasomes: master switches of inflammation

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

The P2X7 receptor: a key player in IL-1 processing and release

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X7 receptor

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Binding, trafficking and accumulation of serum amyloid A in peritoneal macrophages

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Involvement of cathepsin B in the processing and secretion of interleukin-1beta in chromogranin A-stimulated microglia.

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

P2X(7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1.

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Inhibitors of cathepsin B.

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Cathepsin cysteine proteases in cardiovascular disease.

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Humoral proinflammatory cytokine and SAA generation profiles and spatio-temporal relationship between SAA and lysosomal cathepsin B and D in murine splenic monocytoid cells during AA amyloidosis

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Cardiovascular disease in rheumatoid arthritis: a step forward

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice

30 November 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1002843

30 November 2024

Identifiers

DOI

0 references